Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Koru Medical Systems Inc
(NQ:
KRMD
)
2.350
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Koru Medical Systems Inc
< Previous
1
2
3
Next >
KORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023
July 31, 2023
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic
July 27, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes
July 10, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer
June 27, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems, Inc. Announces 2023 First Quarter Financial Results
May 04, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023
April 21, 2023
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022
March 08, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
February 22, 2023
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems Announces Subcutaneous Immunoglobulin Prefilled Syringe Development Agreement
January 25, 2023
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Participate in the Piper Sandler 34th Annual Healthcare Conference
November 21, 2022
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems to Participate in Upcoming Investor Conferences
November 10, 2022
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems Announces 2022 Third Quarter Financial Results
November 09, 2022
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems Announces Novel Therapy Collaboration for Three Indications with Kira Pharmaceuticals
November 08, 2022
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Report Third Quarter 2022 Financial Results on November 9, 2022
October 26, 2022
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems to Participate in Upcoming Industry Conferences
October 17, 2022
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems Appoints Brent Rutland as Vice President of Medical Affairs
October 12, 2022
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium
October 05, 2022
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems Announces 2022 Second Quarter Financial Results
August 03, 2022
From
KORU Medical Systems, Inc.
Via
Business Wire
KORU Medical Systems to Report Second Quarter 2022 Financial Results on August 3, 2022
July 20, 2022
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems Announces 2022 First Quarter Financial Results
May 04, 2022
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELI® (pegcetacoplan), Expands European Label for FreedomEdge®
May 02, 2022
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems to Report First Quarter 2022 Financial Results on May 4, 2022
April 20, 2022
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems Appoints Brian Case As Chief Technology Officer
April 18, 2022
From
KORU Medical Systems
Via
Business Wire
CORRECTING and REPLACING KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022
February 22, 2022
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2021
February 16, 2022
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems Receives FDA 510(k) Clearance for the Use of the FREEDOM60® with Two Additional SCIg Drugs
December 21, 2021
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems to Unveil Updated Strategic Plan at Investor Day
December 01, 2021
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems Announces 2021 Third Quarter Financial Results
November 10, 2021
From
KORU Medical Systems
Via
Business Wire
KORU Medical Announces FDA Clearance for Delivery of Hizentra® Prefilled Syringes
November 10, 2021
From
KORU Medical Systems
Via
Business Wire
KORU Medical Systems to Participate in Two Upcoming Conferences
November 09, 2021
From
KORU Medical Systems
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.